Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Harrisburg Wellness Reporter.
Press releases published on October 9, 2025
Vytala™ Announces New Clinical Data and IRB Approval for Seracal™
Two abstracts to be presented at leading medical conferences highlight broadening clinical use of Seracal™ and a new IRB approval DOWNINGTON, PA, UNITED STATES, October 9, 2025 /EINPresswire.com/ -- Vytala, a healthcare-focused food technology company, …
Shamrock Medicine Offers Psychiatric Care and Wellness Services in Cherry Hill, NJ
Board-certified practice provides mental health support and primary care to adults and young professionals in Cherry Hill. PHILADELPHIA, PA, UNITED STATES, October 9, 2025 /EINPresswire.com/ -- Shamrock Medicine, a boutique family medicine and …
LeMaitre Will Announce Third Quarter 2025 Earnings Results on November 6, 2025
BURLINGTON, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2025 financial results on Thursday, November 6, 2025, after the market close. The company has scheduled a …
Portsmouth Square, Inc. Announces FY2025 Results; Going-Concern Doubt Alleviated Following March 2025 Hotel Refinancing and Strong Operating Trends
Los Angeles, CA, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Portsmouth Square, Inc. ("Portsmouth" or the "Company") (OTC: PRSI) reported results for the fiscal year ended June 30, 2025 and announced that the substantial doubt about the Company's ability to continue …
Clover Health Comments on 2026 Medicare Advantage Star Ratings and Trajectory for Increasing Profitability into 2027
Company underscores differentiated business model; reiterates confidence in its ability to drive above-market membership growth and increasing Adjusted EBITDA profitability1 through 2027, independent of Star ratings WILMINGTON, Del., Oct. 09, 2025 (GLOBE …
Biogen and Stoke Therapeutics Present New Data at the 54th Child Neurology Society (CNS) Annual Meeting that Support the Potential of Zorevunersen as a Disease-Modifying Medicine for Dravet Syndrome
– An analysis designed to evaluate the potential effects of the Phase 3 zorevunersen dosing regimen showed continuing improvements in cognition and behavior at 2 years; results contrast with minimal change in natural history – – Improvements in overall …
Shuttle to Enter $3.24 Billion AI Pharmaceutical Market
GAITHERSBURG, Md., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company, today announced the execution of a non- …
Resmed to Report First Quarter Fiscal 2026 Earnings on October 30, 2025
SAN DIEGO, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2026 on Thursday, October 30, 2025, after the New York Stock Exchange …
OrthoPediatrics Corp. Announces Preliminary Third Quarter 2025 Revenue and Revised 2025 Guidance
WARSAW, Ind., Oct. 09, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced preliminary unaudited financial …
TELA Bio Announces Addition of Betty Jo Rocchio to Board of Directors and the Departure of Director Lisa Colleran
MALVERN, Pa., Oct. 09, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio”) (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the appointment of Betty Jo …
Nurix Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
Announced clinical development plans for bexobrutideg, including the initiation of pivotal trials in relapsed/refractory CLL in H2 2025 Presented preclinical data at EADV 2025 for GS-6791 (NX-0479), a novel IRAK4 degrader in collaboration with Gilead, …
The American Journal of Managed Care® congratulates Jane M. Zhu, M.D., MPP, MSHP, on receiving the 2025 Seema S. Sonnad Emerging Leader in Managed Care Research Award
MONROE, N.J., Oct. 09, 2025 (GLOBE NEWSWIRE) -- The American Journal of Managed Care® (AJMC®), the leading peer-reviewed journal dedicated to issues in managed care, is pleased to recognize Jane M. Zhu, M.D., MPP, MSHP, as the recipient of the 2025 AJMC …
Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
ACTON, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing near-patient solutions for critical care, today announced that it has entered into definitive …
Smith+Nephew announces new category I CPT® code for its CARTIHEAL™ AGILI-C™ Cartilage Repair Implant
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that the American Medical Association (AMA) CPT Editorial Panel has established a Category I Current Procedural Terminology (CPT) code for procedures involving its …
Childhood Cancer Deserves Year-Round Commitment to Funding and Research
HOUSTON, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Five mothers who each lost a child to Ewing sarcoma, an aggressive pediatric cancer, have joined forces in a groundbreaking act of love and advocacy. Brought together by The Faris Foundation, they launched a $1.5 …
Cabaletta Bio Presents First Rese-cel Data with No Preconditioning Demonstrating Biologic Activity and Early Clinical Responses at the 2025 ESGCT Annual Congress
– Complete B cell depletion, rapid reduction in autoantibodies and near-complete resolution of clinical symptoms in two of three refractory patients; all three patients remained off immunomodulators since infusion and are off or tapering steroids as of the …
Die ICPO Foundation begrüßt 24 neue ICPO Theranostics Clinical Centers of Excellence in ihrem globalen Netzwerk von nun 45 Centern
Die Center Certification Ceremony fand am 4. Oktober 2025 anlässlich der Jahreskonferenz der European Association of Nuclear Medicine (EANM) in Barcelona statt. 9. Oktober 2025 – Wiesbaden, Deutschland. Die International Centers for Precision Oncology ( …
ICPO Foundation welcomes 24 new ICPO Theranostics Clinical Centers of Excellence to its global network of 45 centers
The Center Certification Ceremony took place during the ICPO Reception on the occasion of the EANM conference on Oct 4, 2025, in Barcelona. October 9, 2025 – Wiesbaden, Germany. The International Centers for Precision Oncology (ICPO) Foundation announced …
Alkeus Pharmaceuticals Announces Presentation of Gildeuretinol Data at the American Academy of Ophthalmology (AAO) 2025 Annual Meeting, October 18-21 in Orlando
CAMBRIDGE, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Alkeus Pharmaceuticals, Inc., a biopharmaceutical company dedicated to preserving the sight of individuals impacted by retinal diseases, today announced that results from its clinical study of …